Vest Financial’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.6M Buy
244,814
+85,897
+54% +$18.8M 0.76% 57
2025
Q1
$35.6M Sell
158,917
-12,727
-7% -$2.85M 0.55% 90
2024
Q4
$56.2M Buy
171,644
+20,427
+14% +$6.69M 1% 26
2024
Q3
$45.4M Buy
151,217
+35,771
+31% +$10.7M 0.88% 65
2024
Q2
$38M Buy
115,446
+8,729
+8% +$2.88M 0.91% 63
2024
Q1
$42.2M Buy
106,717
+34,523
+48% +$13.7M 1.12% 20
2023
Q4
$25.4M Buy
72,194
+11,639
+19% +$4.1M 0.95% 66
2023
Q3
$22.7M Buy
60,555
+27,935
+86% +$10.5M 1.24% 13
2023
Q2
$12.4M Sell
32,620
-6,578
-17% -$2.49M 1.15% 33
2023
Q1
$13.6M Buy
39,198
+572
+1% +$198K 1.85% 1
2022
Q4
$9.09M Buy
38,626
+9,677
+33% +$2.28M 1.42% 53
2022
Q3
$7.12M Buy
28,949
+1,965
+7% +$484K 1.35% 61
2022
Q2
$8.29M Buy
26,984
+5,137
+24% +$1.58M 1.51% 45
2022
Q1
$8.97M Buy
21,847
+5,703
+35% +$2.34M 1.63% 16
2021
Q4
$7.57M Buy
16,144
+2,454
+18% +$1.15M 1.65% 16
2021
Q3
$5.81M Buy
13,690
+1,355
+11% +$575K 1.77% 3
2021
Q2
$4.43M Buy
12,335
+3,997
+48% +$1.44M 1.68% 6
2021
Q1
$2.35M Buy
+8,338
New +$2.35M 1.35% 62